Myriad Genetics
Trading under the ticker MYGN, Myriad Genetics is a healthcare publicly traded company based in Utah. The company was founded in 1992 and is headquartered in Utah. It operates in the healthcare sector. Corporate records list 2 subsidiaries under the company. Its most recent annual filing reported revenue of about 825 million dollars for fiscal 2025, per SEC 10-K filed 2026-02-24. These figures are factual reference only and are not investment advice. Key people associated with the company include Mark Skolnick (Founder). Facts on this page are drawn from public sources including SEC EDGAR, Wikidata, and the company's own disclosures, each linked below.
Company facts
| Headquarters | Salt Lake City, Utah |
|---|---|
| Founded | 1992 |
| Type | public |
| Ticker | MYGN |
| Subsidiaries | Myriad Genetics (Germany), Myriad Rules-Based Medicine (United States) |
| Website | myriad.com/ |
Financials
$825M revenue for fiscal 2025 ($824,500,000).
| Fiscal year | Revenue | Source |
|---|---|---|
| 2025 | $825M | SEC 10-K filed 2026-02-24 |
| 2024 | $838M | SEC 10-K filed 2026-02-24 |
| 2023 | $753M | SEC 10-K filed 2026-02-24 |
| 2022 | $678M | SEC 10-K filed 2025-02-28 |
| 2021 | $691M | SEC 10-K filed 2024-02-28 |
Key people
- Mark Skolnick — Founder
Jobs at Myriad Genetics
Search current openings at Myriad Genetics →
This is an affiliate link to a third-party job board. See our disclosure.
Frequently asked questions
Where is Myriad Genetics located?
Myriad Genetics is based in Salt Lake City, Utah.
When was Myriad Genetics founded?
Myriad Genetics was founded in 1992.
Is Myriad Genetics publicly traded?
Yes. Myriad Genetics is a public company trading under the ticker MYGN.
What industry is Myriad Genetics in?
Myriad Genetics operates in healthcare.
Related companies
Sources
- Wikipedia (facts only; descriptions on this page are original)
- Wikidata Q3331496 (CC0)
- SEC EDGAR filings (public domain), CIK 0000899923